Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation
Status:
Not yet recruiting
Trial end date:
2025-06-12
Target enrollment:
Participant gender:
Summary
This is an open, one-arm study to evaluate the safety and efficacy of mRNA personalized tumor
vaccine (tumor vaccine) encoding neonatal antigen in combination with Sintilimab injection
for adjuvant prevention of postoperative recurrence of hepatocellular carcinoma.